The global neuroscience market size reached USD 35.9 Billion in 2024 and is expected to grow to USD 48.0 Billion by 2033. This represents a CAGR of 3.1% during the forecast period 2025-2033. Growth is driven by increasing neurological disorder prevalence, investment in R&D, advancements in neuroimaging, mental health awareness, aging populations, and supportive government policies. 

Study Assumption Years

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033

Neuroscience Market Key Takeaways

• Current Market Size: USD 35.9 Billion in 2024
• CAGR: 3.1% (2025-2033)
• Forecast Period: 2025-2033
• There is a rising occurrence of neurological disorders such as epilepsy driving market growth.
• Increasing funding by governments and private sectors accelerates neuroscience research and treatment development.
• North America leads the market due to high investments and presence of key companies and institutions.
• Asia Pacific is poised for rapid growth driven by healthcare spending and government initiatives like China's "China Brain Project".
• Technological advances include AI-powered diagnostic systems and ultra-miniature neuro-microscopes improving diagnosis and treatment.

Sample Request Link: 

https://www.imarcgroup.com/neuroscience-market/requestsample

Market Growth Factors

Increasing Prevalence of Neurological Disorders

The neuroscience market is expanding mainly due to the rising prevalence of neurological disorders such as Alzheimer's, Parkinson's disease, brain cancer, and epilepsy. Alzheimer's cases in the US alone are projected to reach 13 million by 2050, fueling the demand for advanced diagnostic and treatment options. This growth is further supported by the increasing aging population, which is more vulnerable to neurodegenerative diseases. These conditions necessitate more targeted and effective therapies, prompting intensified research and development.

Rising Investment in Neuroscience Research and Development

Funding from public institutions, governments, philanthropic organizations, and private enterprises in the neuroscience sector has surged significantly. These investments support brain function research, neural data integration, drug development, and advanced technologies, such as brain mapping. Companies like B. Braun SE and GE Healthcare contribute by producing durable consumables and instruments that enhance neurological care efficiency. This financial influx accelerates discovery and facilitates translation of research into practical clinical applications.

Technological Advancements in Neuroimaging Tools

Recent technological progress in neuroimaging tools including MRI, PET, and EEG has led to better resolution, faster imaging, and more precise analysis of neurological conditions. Additional innovations in neuro-microscopy by companies such as Danaher Corporation and Carl Zeiss AG, including ultra-miniature electronic microscopes, allow the detection and potential reversal of neurological damage. These advancements enable clinicians and researchers to improve diagnosis, treatment plans, and overall capabilities in neuroscience.

Market Segmentation

By Component:

• Instruments and Consumables: This segment dominates the market, driven by demand for advanced diagnostic and surgical tools, technological enhancements for accuracy, and applications in genomic and proteomic research. It benefits from rising global healthcare expenditure and regulations requiring certified and sterile equipment.
• Software and Services

By Technology:

• Brain Imaging: The largest segment due to rising neurological disorders demanding early, accurate diagnosis through advanced technologies like MRI, PET, CT, integrated with AI and machine learning for improved diagnostic precision.
• Neuro-Microscopy
• Electrophysiology
• Neuroproteomic Analysis
• Animal Behaviour Analysis
• Others

By End User:

• Hospitals: Fastest growth driven by increasing neurological admissions and expanded healthcare infrastructure enhancing demand for sophisticated diagnostics and therapies.
• Diagnostic Laboratories: Growth fueled by disease prevalence needing accurate diagnosis, adoption of molecular diagnostics, next-generation sequencing, and biomarker analysis.
• Research and Academic Institutes: Expanding due to broad scientific research scope supported by grants and collaborations for drug and therapy development.
• Others: Includes clinics and ambulatory surgical centers focusing on outpatient services and preventive care.

By Region:

• North America: Leads the neuroscience market with the largest share due to high prevalence of chronic diseases, strong healthcare infrastructure, and notable innovations.
• Asia Pacific: Fastest growth region, propelled by healthcare investments, large population, and projects like China Brain Project.
• Europe
• Latin America
• Middle East and Africa

Regional Insights

North America dominates the global neuroscience market owing to high incidences of chronic diseases such as diabetes, cardiovascular conditions, and obesity, alongside substantial healthcare investments and presence of major industry players. This region benefits from innovation and commercialization capabilities, exemplified by products like CERENOVUS' EMBOGUARD catheter introduced in 2022. Asia Pacific is the fastest-growing market fueled by increasing healthcare expenditure and initiatives such as China’s "China Brain Project" with investment over USD 746 Million.

Recent Developments & News

In 2021, Blackrock Neurotech developed a wireless brain-computer interface (BCI) system for clinical and research use, enhancing patient comfort by eliminating wired connections. In 2022, Kernel launched Kernel Flow, a non-invasive brain recording device using advanced time-domain functional near-infrared spectroscopy (TD-fNIRS) technology, designed for clinical and consumer neuroscience research with high spatial and temporal resolution.

Key Players

• Alpha Omega Engineering
• Biobserve GmbH
• Blackrock Neurotech
• Doric Lenses Inc.
• General Electric Company
• Kernel
• Laserglow Technologies
• Mightex Systems
• NeuroNexus Technologies Inc.
• Noldus Information Technology B.V.
• Plexon Inc.
• Prizmatix Ltd.
• Siemens AG

Get Custom Market Research Report for Your Business:

https://www.imarcgroup.com/request?type=report&id=5133&flag=E

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302